[VIEW] agent=Data Governance & Privacy Officer | scenario_id=117 | rounds=20

--- Round 0 ---
[R0.1] Data Governance & Privacy Officer (speak, public): To ensure we are aligned, could we discuss the specific data elements and the delivery cadence you are requesting for the oncology outcomes registry? Additionally, are there any high-risk content requests or unresolved security concerns that we need to address?
[R0.2] Oncology Research Program Manager (speak, public): Thank you for bringing this up. For the oncology outcomes registry, we're looking at 38 required fields, which will include details like stage and regimen but will exclude imaging files. The data submission will be quarterly, with a 14-day window after each quarter-end for submissions. Regarding high-risk content requests, I don't foresee any at this moment, but I would like to ensure we confirm the governance and contracting path as well as any potential delivery constraints. Are there any concerns or compliance history we should be aware of?
[R0.3] Enterprise Data Platform & Security Lead (speak, public): Thank you for the details on the required fields and the submission timeline. Given that the data will be submitted quarterly, I would like to confirm that we have the right governance mechanisms in place to handle this volume of data efficiently. Additionally, while you mentioned no high-risk content requests at this time, it would be prudent to establish a monitoring framework in case any issues arise in the future. Can we outline the steps needed for governance and contracting to ensure everything is in order for the data-sharing program?

--- Round 1 ---
[R1.1] Data Governance & Privacy Officer (speak, private to=Oncology Research Program Manager,Enterprise Data Platform & Security Lead): I appreciate the clarity on the data elements and submission timeline. To proceed effectively, I would like to confirm the current status of the Data Use Agreement, specifically the open clauses regarding redisclosure, audit rights, and destruction. This is crucial for our governance and compliance framework. Can we ensure that these will be addressed satisfactorily before we move forward?
[R1.2] Oncology Research Program Manager (speak, private to=Data Governance & Privacy Officer,Enterprise Data Platform & Security Lead): To ensure we keep the registry launch on track, I will follow up on the Data Use Agreement and the specific clauses mentioned. Can we confirm that the open clauses concerning redisclosure, audit rights, and destruction will be addressed? This clarity is essential for our governance and compliance framework moving forward.
[R1.3] Enterprise Data Platform & Security Lead (speak, private to=Data Governance & Privacy Officer,Oncology Research Program Manager): I agree that addressing the open clauses in the Data Use Agreement is critical. Let's ensure we have a clear understanding of the redisclosure, audit rights, and destruction clauses, and confirm that these will be resolved in a timely manner to keep our project on track. Additionally, I would like to discuss the monitoring framework further to ensure we are prepared for any unforeseen issues down the line. Can we set a timeline for these actions?

--- Round 2 ---
[R2.1] Data Governance & Privacy Officer (speak, private to=Oncology Research Program Manager,Enterprise Data Platform & Security Lead): Thank you both for your commitment to addressing the open clauses in the Data Use Agreement. To keep the project on schedule, let's confirm a timeline for resolving these issues. Additionally, I propose that we establish a clear monitoring framework to proactively identify any high-risk requests as the project progresses. Can we set a meeting to outline these next steps?
[R2.2] Oncology Research Program Manager (speak, private to=Data Governance & Privacy Officer,Enterprise Data Platform & Security Lead): I appreciate everyone's input on the Data Use Agreement and the need for a monitoring framework. Let's set a meeting to finalize the timeline for resolving the open clauses concerning redisclosure, audit rights, and destruction. It's crucial we keep everything on track for the registry launch. Can we aim to have this meeting by the end of the week?
[R2.3] Enterprise Data Platform & Security Lead (speak, private to=Data Governance & Privacy Officer,Oncology Research Program Manager): I agree that we need to set a meeting by the end of the week to finalize the timeline for addressing the open clauses in the Data Use Agreement. It’s essential to ensure we have a robust monitoring framework in place as we move forward. Can we confirm a time that works for everyone?

--- Round 3 ---
[R3.1] Data Governance & Privacy Officer (speak, private to=Oncology Research Program Manager,Enterprise Data Platform & Security Lead): I agree that setting a meeting by the end of the week is essential. Let's confirm a time that suits all of us to finalize the timeline for the Data Use Agreement clauses and discuss the monitoring framework further. It's important we stay on track for the registry launch.
[R3.2] Oncology Research Program Manager (speak, private to=Data Governance & Privacy Officer,Enterprise Data Platform & Security Lead): Let's propose a meeting time by Friday to finalize our timeline regarding the Data Use Agreement and monitoring framework. This will ensure we stay aligned and on schedule for the registry launch. What time works best for everyone?
[R3.3] Enterprise Data Platform & Security Lead (speak, private to=Data Governance & Privacy Officer,Oncology Research Program Manager): Let's aim for Friday at 2 PM for our meeting to finalize the timeline regarding the Data Use Agreement and the monitoring framework. Does that work for everyone?

--- Round 4 ---
[R4.1] Data Governance & Privacy Officer (speak, private to=Oncology Research Program Manager,Enterprise Data Platform & Security Lead): Friday at 2 PM works for me. I look forward to finalizing the timeline for the Data Use Agreement and discussing the monitoring framework then. Thank you both for your collaboration.
[R4.2] Oncology Research Program Manager (speak, private to=Data Governance & Privacy Officer,Enterprise Data Platform & Security Lead): Friday at 2 PM works for me as well. I appreciate everyone's collaboration and I look forward to finalizing our timeline for the Data Use Agreement and discussing the monitoring framework then.
[R4.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 5 ---
[R5.1] Data Governance & Privacy Officer (leave, public): 
[R5.2] Oncology Research Program Manager (leave, public): 
[R5.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 6 ---
[R6.1] Data Governance & Privacy Officer (leave, public): 
[R6.2] Oncology Research Program Manager (leave, public): 
[R6.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 7 ---
[R7.1] Data Governance & Privacy Officer (leave, public): 
[R7.2] Oncology Research Program Manager (leave, public): 
[R7.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 8 ---
[R8.1] Data Governance & Privacy Officer (leave, public): 
[R8.2] Oncology Research Program Manager (leave, public): 
[R8.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 9 ---
[R9.1] Data Governance & Privacy Officer (leave, public): 
[R9.2] Oncology Research Program Manager (leave, public): 
[R9.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 10 ---
[R10.1] Data Governance & Privacy Officer (leave, public): 
[R10.2] Oncology Research Program Manager (leave, public): 
[R10.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 11 ---
[R11.1] Data Governance & Privacy Officer (leave, public): 
[R11.2] Oncology Research Program Manager (leave, public): 
[R11.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 12 ---
[R12.1] Data Governance & Privacy Officer (leave, public): 
[R12.2] Oncology Research Program Manager (leave, public): 
[R12.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 13 ---
[R13.1] Data Governance & Privacy Officer (leave, public): 
[R13.2] Oncology Research Program Manager (leave, public): 
[R13.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 14 ---
[R14.1] Data Governance & Privacy Officer (leave, public): 
[R14.2] Oncology Research Program Manager (leave, public): 
[R14.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 15 ---
[R15.1] Data Governance & Privacy Officer (leave, public): 
[R15.2] Oncology Research Program Manager (leave, public): 
[R15.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 16 ---
[R16.1] Data Governance & Privacy Officer (leave, public): 
[R16.2] Oncology Research Program Manager (leave, public): 
[R16.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 17 ---
[R17.1] Data Governance & Privacy Officer (leave, public): 
[R17.2] Oncology Research Program Manager (leave, public): 
[R17.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 18 ---
[R18.1] Data Governance & Privacy Officer (leave, public): 
[R18.2] Oncology Research Program Manager (leave, public): 
[R18.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 19 ---
[R19.1] Data Governance & Privacy Officer (leave, public): 
[R19.2] Oncology Research Program Manager (leave, public): 
[R19.3] Enterprise Data Platform & Security Lead (leave, public): 

